stockrow
Friday 6 November 2026
Export QUCY’s income statement to Excel — free account
Quantum Cyber N.V
QUCY Healthcare Diagnostics & Research
Quantum Cyber N.V’s revenue for fiscal 2025 (year ended December 2025) was $537,100.00, down 39.9% from fiscal 2024.
- EPS
- +96.0%
- Free cash flow
- +26.7%
Quarter to June 2026, against a year earlier
0.71
0.01
+1.43%
Follow QUCY
Alert me
| Dec '17 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 4 | 5 | 2 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 0.00 | 176.32 | 21.22 | 1.96 | 4.29 |
Altman Z-Score |
— | — | 7.75 | 3.39 | (11.04) | (13.21) | (37.02) |
Altman Z″-Score (non-manufacturers) |
— | (36.58) | (4.70) | (8.72) | (26.12) | (29.03) | (86.69) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (20,975.51) | (1,550.11) | (19.82) | (4.08) | (0.22) | (1.49) |
Beneish M-Score |
— | — | (8.07) | (5.73) | (2.30) | (4.33) | (6.10) |
P/B ratio |
— | 21,588.83 | 784.67 | 6.63 | 5.85 | 0.00 | 5.99 |
Price to Tangible BV |
— | 21,588.83 | 784.67 | 6.63 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 145.92 | 20.14 | 8.60 | 5.27 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 | (5.24) | (0.82) | (0.32) | (0.24) |
EV/FCF |
— | 0.00 | 0.00 | (5.01) | (0.76) | (0.30) | (0.23) |
Quick Ratio |
— | 0.24 | 6.54 | 4.06 | 0.78 | 1.02 | 0.26 |
Current Ratio |
— | 0.27 | 7.11 | 4.33 | 0.97 | 1.30 | 0.50 |
Net Debt/EBITDA |
— | (1.40) | 0.86 | 0.62 | 0.04 | 0.23 | (0.01) |
Debt/Assets |
0.00% | 145.67% | 4.64% | 5.11% | 39.60% | 15.10% | 20.17% |
Debt/Equity |
— | (0.36) | 0.07 | 0.07 | 1.88 | 0.34 | 1.68 |
Asset Turnover |
— | 1.47 | 0.11 | 0.04 | 0.05 | 0.06 | 0.06 |
Operating CF/Net income |
— | 0.80 | 0.28 | 0.56 | 0.83 | 0.80 | 0.68 |
Capex/Depreciation |
— | (0.16) | (0.24) | (1.73) | (2.19) | (0.33) | (1.68) |
Interest Coverage |
— | (3.82) | (48.82) | (126.10) | (32.91) | (19.86) | (43.21) |
| — | 0.00% | (645.93%) | (257.97%) | (303.20%) | (467.15%) | (488.32%) | |
| — | (174.34%) | (218.22%) | (174.28%) | (147.52%) | (149.42%) | (172.19%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (730.26%) | (651.38%) | (1,219.26%) |
Return on Tangible Assets |
— | 120.94% | (140.92%) | (178.32%) | (1,819.39%) | (674.23%) | 2,142.29% |
Average Days of Receivables |
— | 32.68 | 70.69 | 46.15 | 38.15 | 20.74 | 53.28 |
Research and Development Expense of Revenue |
— | 63.19% | 80.84% | 947.24% | 1,070.95% | 684.14% | 923.59% |
Selling, General and Administrative Expense of Revenue |
— | 98.24% | 1,634.42% | 4,077.52% | 1,961.36% | 1,480.08% | 1,662.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.22 | 0.21 |
Share Based Compensation of Revenue |
— | 0.00% | 1,113.84% | 1,853.97% | 447.30% | 103.33% | 498.08% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.13 | (0.17) | (5.82) | (0.12) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (9.84%) | (9.84%) | (28.24%) | (142.49%) | (1,543.63%) | (4,477.07%) |
Free Cash Flow Yield |
— | 0.00% | 0.00% | (16.51%) | (125.42%) | (1,444.56%) | (532.18%) |
Revenue per Share |
— | 3.52 | 3.20 | 1.50 | 2.21 | 0.91 | 0.09 |
Operating CF per Share |
— | (3.34) | (17.86) | (41.73) | (54.02) | (17.58) | (1.83) |
Capex per Share |
— | (0.07) | (0.09) | (1.86) | (4.68) | (0.23) | (0.17) |
Free Cash Flow per Share |
— | (3.41) | (17.95) | (43.59) | (58.70) | (17.82) | (2.00) |
Cash per Share |
— | 0.87 | 48.41 | 48.44 | 17.41 | 6.33 | 0.15 |
Shareholders Equity per Share |
— | (19.55) | 35.28 | 39.83 | 8.00 | 6.08 | 0.11 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (19.55) | 35.28 | 39.83 | 8.00 | 6.08 | 0.11 |
Free Cash Flow |
— | (0.48) | (3.24) | (15.43) | (23.84) | (17.56) | (12.01) |
Working Capital |
— | (0.52) | 8.26 | 14.14 | (0.26) | 1.84 | (1.85) |
Capital Expenditures |
— | (0.01) | (0.02) | (0.66) | (1.90) | (0.23) | (1.03) |
Net Current Asset Value |
— | (3.23) | 5.93 | 12.23 | (3.18) | 0.52 | (2.84) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.02 | 0.03 | 1.24 | 2.12 | 0.26 | 1.92 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | 2.00 | 1.84 | 0.57 | 0.51 | 0.51 | 0.56 |
Cash ROIC |
— | 29.20% | (20.81%) | (47.81%) | (145.15%) | (123.04%) | (461.06%) |
Accounts Receivable Turnover |
— | 0.00 | 7.40 | 5.93 | 11.15 | 12.38 | 8.31 |
Accounts Payable Turnover |
— | 0.00 | 0.68 | 0.20 | 0.12 | 0.10 | 0.08 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.98 | 0.65 | 0.50 |
Average Days of Payables |
— | 393.18 | 716.67 | 2,852.50 | 3,296.45 | 3,355.00 | 2,355.03 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 184.23 | 580.52 | 426.54 | 537.46 |
Average Receivables |
— | — | 0.08 | 0.09 | 0.08 | 0.07 | 0.06 |
Average Payables |
— | — | 0.59 | 1.75 | 3.10 | 3.21 | 1.94 |
Average Inventory |
— | — | — | — | 0.39 | 0.49 | 0.29 |
Average Assets |
— | 0.34 | 5.36 | 15.14 | 17.83 | 14.46 | 9.41 |
Average Common Equity |
— | — | 1.81 | 10.23 | 8.67 | 4.62 | 3.32 |
Columns are period end dates · fundamentals updated 25 Oct 2026